Key result
The SOX-PTS and Méan clinical models accurately predicted postthrombotic syndrome at 6 months, whereas the Amin model did not.
Why the study?
The SOX-PTS, Amin, and Méan models stratify the risk of postthrombotic syndrome after acute deep vein thrombosis, but they had not been compared head-to-head in the same patient cohort.
Do the SOX-PTS, Amin, and Méan clinical prediction models accurately predict the occurrence of postthrombotic syndrome in patients with acute deep vein thrombosis?
Cohort (n=181)
Do the SOX-PTS, Amin, and Méan clinical prediction models accurately predict the occurrence of postthrombotic syndrome in patients with acute deep vein thrombosis?
The SOX-PTS and Méan clinical prediction models demonstrate good accuracy for stratifying the risk of postthrombotic syndrome in patients with acute DVT, outperforming the Amin model.
Answers are grounded in this paper and cite their sources.
May aid PTS risk stratification after acute DVT with SOX-PTS or Méan models; leaves open need for prospective validation.
OBJECTIVE: The SOX-PTS, Amin, and Méan models are three different clinical prediction scores stratifying the risk for postthrombotic syndrome (PTS) development in patients with acute deep vein thrombosis (DVT) of the lower limbs. Herein, we aimed to assess and compare these scores in the same cohort of patients. METHODS: We retrospectively applied the three scores in a cohort of 181 patients (196 limbs) who participated in the SAVER pilot trial for an acute DVT. Patients were stratified into PTS risk groups using positivity thresholds for high-risk patients as proposed in the derivation studies. All patients were assessed for PTS 6 months after index DVT using the Villalta scale. We calculated the predictive accuracy for PTS and area under receiver operating characteristic (AUROC) curve for each model. RESULTS: The Méan model was the most sensitive (sensitivity 87.7%; 95% confidence interval [CI]: 77.2-94.5) with the highest negative predictive value (87.5%; 95% CI: 76.8-94.4) for PTS. The SOX-PTS was the most specific score (specificity 97.5%; 95% CI: 92.7-99.5) with the highest positive predictive value (72.7%; 95% CI: 39.0-94.0). The SOX-PTS and Méan models performed well for PTS prediction (AUROC: 0.72; 95% CI: 0.65-0.80 and 0.74; 95% CI: 0.67-0.82), whereas the Amin model did not (AUROC: 0.58; 95% CI: 0.49-0.67). CONCLUSION: Our data support that the SOX-PTS and Méan models have good accuracy to stratify the risk for PTS.
No takes yet. Share an insight, caveat, or question.
Pradier et al. (2023) conducted a cohort in Acute deep vein thrombosis (DVT) of the lower limbs (n=181). SOX-PTS, Amin, and Méan clinical prediction models was evaluated on Postthrombotic syndrome (PTS) at 6 months (AUROC 0.74 for Méan model, 0.72 for SOX-PTS model, 95% CI 0.67-0.82 for Méan, 0.65-0.80 for SOX-PTS). The SOX-PTS and Méan clinical models accurately predicted postthrombotic syndrome at 6 months, whereas the Amin model did not.
Synapse has enriched 10 related papers. Consider them for comparative context: